STRS Ohio’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $200K | Sell |
14,300
-9,500
| -40% | -$133K | ﹤0.01% | 1661 |
|
2025
Q1 | $324K | Hold |
23,800
| – | – | ﹤0.01% | 1369 |
|
2024
Q4 | $485K | Buy |
23,800
+6,400
| +37% | +$130K | ﹤0.01% | 1224 |
|
2024
Q3 | $507K | Hold |
17,400
| – | – | ﹤0.01% | 1256 |
|
2024
Q2 | $404K | Buy |
17,400
+4,400
| +34% | +$102K | ﹤0.01% | 1342 |
|
2024
Q1 | $266K | Sell |
13,000
-800
| -6% | -$16.4K | ﹤0.01% | 1477 |
|
2023
Q4 | $296K | Hold |
13,800
| – | – | ﹤0.01% | 1461 |
|
2023
Q3 | $284K | Hold |
13,800
| – | – | ﹤0.01% | 1469 |
|
2023
Q2 | $407K | Sell |
13,800
-8,100
| -37% | -$239K | ﹤0.01% | 1368 |
|
2023
Q1 | $504K | Sell |
21,900
-11,800
| -35% | -$272K | ﹤0.01% | 1311 |
|
2022
Q4 | $937K | Hold |
33,700
| – | – | ﹤0.01% | 961 |
|
2022
Q3 | $1.03M | Hold |
33,700
| – | – | ﹤0.01% | 879 |
|
2022
Q2 | $991K | Buy |
33,700
+2,800
| +9% | +$82.3K | ﹤0.01% | 927 |
|
2022
Q1 | $994K | Hold |
30,900
| – | – | ﹤0.01% | 1042 |
|
2021
Q4 | $1.38M | Hold |
30,900
| – | – | ﹤0.01% | 934 |
|
2021
Q3 | $1.56M | Sell |
30,900
-300
| -1% | -$15.1K | 0.01% | 836 |
|
2021
Q2 | $2.45M | Buy |
31,200
+4,600
| +17% | +$361K | 0.01% | 669 |
|
2021
Q1 | $1.52M | Buy |
26,600
+6,800
| +34% | +$388K | 0.01% | 878 |
|
2020
Q4 | $1.66M | Buy |
19,800
+7,900
| +66% | +$662K | 0.01% | 786 |
|
2020
Q3 | $426K | Hold |
11,900
| – | – | ﹤0.01% | 1421 |
|
2020
Q2 | $287K | Sell |
11,900
-20,900
| -64% | -$504K | ﹤0.01% | 1547 |
|
2020
Q1 | $574K | Hold |
32,800
| – | – | ﹤0.01% | 1035 |
|
2019
Q4 | $571K | Hold |
32,800
| – | – | ﹤0.01% | 1380 |
|
2019
Q3 | $502K | Hold |
32,800
| – | – | ﹤0.01% | 1278 |
|
2019
Q2 | $680K | Buy |
+32,800
| New | +$680K | ﹤0.01% | 1035 |
|
2018
Q2 | – | Sell |
-4,600
| Closed | -$90K | – | 2132 |
|
2018
Q1 | $90K | Buy |
+4,600
| New | +$90K | ﹤0.01% | 1639 |
|